期刊文献+

2014年供血浆人群及血液制品戊型肝炎病毒感染情况分析 被引量:3

Analysis of HEV infection in plasma donors and blood products in 2014
原文传递
导出
摘要 目的分析2014年供血浆人群及血液制品的戊型肝炎病毒(hepatitis E virus,HEV)HEV感染情况。方法采用ELISA法对不同省份(四川省、山东省、山西省)供血浆人群血浆样品进行HEV Ag、HEV Ig M和HEV Ig G的检测,并对HEV Ag阳性供血浆者作追踪分析;对合并血浆及血液制品成品进行HEV Ag检测。结果 36 340份供血浆者样品中有HEV Ag阳性26份(0.07%);3 780份血浆样品中有HEV Ig G阳性1 519份(40.19%),HEV Ig M阳性34份(0.90%)。115批合并血浆样品及113批血液制品成品中的HEV Ag检测结果均为阴性。结论调查的供血浆人群HEV阳性率存在地区差异,血液制品的安全性较高。 Objective To analyze the prevalence of hepatitis E virus(HEV)infection in plasma donors and blood products in 2014. Methods The plasma samples of donors from various provinces(Sichuan,Shandong and Shanxi)were determined for HEV Ag,HEV Ig M and HEV Ig G by ELISA,of which the positive ones were traced. The final product and pooled plasma were determined for HEV Ag. Results Of the 36 340 samples,26(0. 07%)were positive for HEV Ag. However,of the3 780 samples,1 519(40. 19%) were positive for HEV Ig G,and 34(0. 90%) for HEV Ig M. All the 113 batches of final products and 115 batches of pooled plasma samples were negative for HEV Ag. Conclusion The HEV positive rates in plasma of donors in various areas showed significant difference. However,the prepared blood products showed high safety.
出处 《中国生物制品学杂志》 CAS CSCD 2015年第12期1294-1296,共3页 Chinese Journal of Biologicals
关键词 戊型肝炎病毒 供血浆人群 抗原 IGG IGM Hepatitis E virus(HEV) Plasma donor Antigen IgG IgM
  • 相关文献

参考文献5

二级参考文献46

共引文献56

同被引文献48

  • 1严根兴,戴利成,吴康丽,查荣宝,姚行,汪峰,何建方,叶玉芳,葛胜祥,郭清顺,夏宁邵.献血者中戊型肝炎病毒血症研究[J].中国输血杂志,2004,17(6):417-419. 被引量:20
  • 2高东英,彭耿,朱家明,孙丽,郑英杰,张军.北京血站献血员戊型肝炎流行病学调查[J].病毒学报,2004,20(4):322-325. 被引量:15
  • 3Meng Xl. Zoonotic and foodbome transmission of hepatitis E virus[J]. Semin Liver Dis, 2013, 33(1): 41-49. DOl: 1O.1055/s- 0033-1338113.
  • 4Kamar N, SelvesJ, MansuyJM, et al. Hepatitis E virus and chro?nic hepatitis in organ-transplant recipients[J]. N EnglJ Med, 2008,358(8): 811-817. DOl: 10.1056/NEJMoa0706992.
  • 5Kamar N, Rostaing L, IzopetJ. Hepatitis E virus infection in im?munosuppressed patients: natural history and therapy[J]. Semin Liver Dis, 2013, 33 ( 1 ): 62-70. DOl: 10. 10551s-0033- 1338115.
  • 6Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants[J]. Gastroenterology, 2011,140(5): 1481-1489. DOl: 1O.1053/j. gastro. 2011. 02. 050.
  • 7Kamar N, MansuyJM, Cointault 0, et al. Hepatitis E virus-relat?ed cirrhosis in kidney- and kidney-pancreas-transplant recipients[J]. AmJ Transplant, 2008, 8(8): 1744-1748. DOl: 10. 11111j. 1600-6143.2008.02286. x.
  • 8Radha Krishna Y, Saraswat V A, Das K, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis[J]. Liver Int, 2009, 29 (3): 392-398. DOl: 10. 11 I lIj. 1478-3231.2008.01887. x.
  • 9Schlosser B, Stein A, Neuhaus R, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cir?rhosis in the recipientJ J}.J Hepatol, 2012, 56(2): 500-502. DOl: 10. 1016/j.Jhep. 2011. 06. 021.
  • 10Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immu?nocompetent patient: a case report[J]. Hepatology, 2014, 59 (I) : 347-348. DOl: 10. 1002/hep. 26636.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部